Tel:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@anticorps-enligne.fr

Receptor-Interacting Serine-threonine Kinase 2 (RIPK2) (Middle Region) Peptide

RIPK2 Reactivité: Humain Hôte: Synthetic BP, WB
N° du produit ABIN5512448

Aperçu rapide pour Receptor-Interacting Serine-threonine Kinase 2 (RIPK2) (Middle Region) Peptide (ABIN5512448)

Antigène

RIPK2 (Receptor-Interacting Serine-threonine Kinase 2 (RIPK2))

Origine

Humain

Source

  • 2
Synthetic

Application

Blocking Peptide (BP), Western Blotting (WB)
  • Protein Region

    Middle Region

    Séquence

    SLNIPVNHGP QEESCGSSQL HENSGSPETS RSLPAPQDND FLSRKAQDCY

    Attributs du produit

    This is a synthetic peptide designed for use in combination with anti- RIPK2 Antibody. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
  • Indications d'application

    Optimal working dilution should be determined by the investigator.

    Restrictions

    For Research Use only
  • Format

    Lyophilized

    Reconstitution

    Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.

    Stock

    -20 °C

    Stockage commentaire

    For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
  • Antigène

    RIPK2 (Receptor-Interacting Serine-threonine Kinase 2 (RIPK2))

    Sujet

    This gene encodes a member of the receptor-interacting protein (RIP) family of serine/threonine protein kinases. The encoded protein contains a C-terminal caspase activation and recruitment domain (CARD), and is a component of signaling complexes in both the innate and adaptive immune pathways. It is a potent activator of NF-kappaB and inducer of apoptosis in response to various stimuli.

    Alias Symbols: CCK, RICK, RIP2, CARD3, GIG30, CARDIAK

    Protein Size: 540

    ID gène

    8767

    NCBI Accession

    NM_003821, NP_003812

    UniProt

    O43353
Vous êtes ici:
Chat with us!